Pharmacokinetic (PK)-driven individualization of pazopanib therapy in patients with solid tumors: A phase 1 study (MC1112).
Year: 2016
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: Mayo Clinic, National Cancer Institute, Mayo Clinic in Arizona
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2789160780
